Acrobat Genomics Analysis
What is Acrobat Genomics?
Acrobat Genomics leverages single-cell genomics and CRISPR gene editing from Stanford University to develop curative therapies for genetic diseases. The company combines DNA technologies with machine learning to accelerate high-throughput biology. Based in MBC BioLabs, San Carlos, CA, it is an early-stage VC-backed biotech startup founded in 2022.
Location
San Carlos, United States
Employees
1-10
Founded
2022
Funding Status
Seed
Product Features & Capabilities
- Single-cell genomics and CRISPR gene editing
- Machine learning for high-throughput biology
- DNA technology platform for therapeutic discovery
Use Cases
Identify novel gene targets for monogenic disorders; Accelerate CRISPR screening for rare genetic conditions; Optimize gene editing efficiency using ML models; Discover therapeutic candidates for inherited retinal diseases; Enable scalable discovery of gene therapies for monogenic diseases
Other Considerations
Founded in 2022; Early-stage VC-backed startup; Based in MBC BioLabs, San Carlos, CA; Supported by Illumina, NIH, DoD, and NVIDIA Inception Program; Stanford University CRISPR lab origin
See something that needs updating? Suggest edits to this profile.